in liver of chicken (Gallus Gallus...According to the predicted Gallus gallus cathepsin E-A-like...
Transcript of in liver of chicken (Gallus Gallus...According to the predicted Gallus gallus cathepsin E-A-like...
RESEARCH ARTICLE
Estrogen regulates the expression of cathepsin E-A-like gene via ERβ
in liver of chicken (Gallus Gallus)
Hang Zheng¶1, Hong Li¶1,2, Wenbo Tan1, Chunlin Xu1, Lijuan Jia1, Dandan Wang1, Zhuanjian
Li1,2, Gunrong Sun1,2, Xiangtao Kang1,2,3, Fengbin Yan1,2*, Xiaojun Liu1,2,3*
1College of Animal Science and Veterinary Medicine, Henan Agricultural University,
Zhengzhou 450002, P. R. China
2Henan Innovative Engineering Research Center of Poultry Germplasm Resource, Henan
Agricultural University, Zhengzhou 450002, P. R. China
3International Joint Research Laboratory for Poultry Breeding of Henan, Henan Agricultural
University, Zhengzhou 450002, P. R. China
Running title:Estrogen regulates cathepsin E-A-like expression via ERβ
Keywords: Estrogen regulation, Cathepsin E-A-like, Chicken, Hepatocytes, Function
analysis, Regulatory mechanism
¶These authors contributed equally to this work.
*Corresponding authors.
Xiaojun Liu.
Email: [email protected]
Disclosure statement: The authors have no conflicts of interest to disclose.
Abstract
The Cathepsin E-A-like, also known as “similar to nothepsin”, is a new member of the
aspartic protease family, which may take part in processing of egg yolk macromolecules,
due to it was identified in the chicken egg yolk. Previous studies have suggested that the
expression of cathepsin E-A-like increased gradually during sexual maturation of pullets, but
the exact regulation mechanism is poorly understood. In this study, to gain insight into the
function and regulation mechanism of the gene in egg-laying hen, we cloned the cathepsin
E-A-like gene, and evaluated its evolutionary origin by using both phylogenetic and syntenic
methods. The mode of the gene expression regulation was analysed through stimulating
juvenile hens with 17β-estradiol, and chicken embryo hepatocytes with 17β-estradiol
combined with estrogen receptor antagonists including MPP, ICI 182,780 and tamoxifen.
Our results showed that cathepsin E-A-like was an orthologous gene with nothepsin, which
was present in birds but lost in mammals. The expression of cathepsin E-A-like significantly
increased in a dose dependent manner after the juvenile hens were treated with 17β-estradiol
(P<0.05). Compared with the 17β-estradiol treatment group, the expression of cathepsin
E-A-like was not significantly changed when the hepatocytes were treated with 17β-estradiol
combined with MPP (P<0.05). In contrast, compared with the 17β-estradiol combined with
MPP treatment group, the expression of cathepsin E-A-like was significantly down-regulated
when the hepatocytes were treated with 17β-estradiol combined with tamoxifen or ICI
182,780 (P<0.05). These results demonstrated that cathepsin E-A-like shared the same
evolutionary origin with nothepsin. The expression of cathepsin E-A-like was regulated
by estrogen, and the regulative effect was predominantly mediated via ER-β in chicken liver.
Keywords: Estrogen Regulation, Cathepsin E-A-like, Chicken, Hepatocytes, Function
analysis, Regulatory mechanism
Introduction
During the egg-laying stage in chicken, proteins and hydrophobic lipids
including triacylglycerols, cholesteryl, cholestery esters, phospholipids and free fatty
acids are synthesized actively in the liver. The proteins and lipids are then assembled
into egg-yolk precursors, such as very-low density lipoprotein and vitellogenin, and
secreted into the circulatory system. The egg-yolk precursors are transferred to the
ovarian follicles and taken-up by the developing oocytes via receptor-mediated
mechanisms to provide energy for the growth and development of the embryo (Brady
et al. 1976; Wiskocil R. 1980; Walzem et al. 1999; Nikolay et al. 2013). The
egg-yolk precursors are further processed by lysosomal enzymes during ovarian
follicle growth and maturation (Retzek et al. 1992; Carnevali et al. 2006; Winchester
2014).
Lysosomal enzymes were first identified in the lysosome and played important
roles in proteolysis during physiological processes, as well as in the immune response
to several diseases (Bohley & Seglen 1992; Winchester 2014; Rama Rao & Kielian
2015). Aspartic proteinases belong to a multi-gene family of lysosomal enzymes that
are distinguished by their structure, catalytic mechanism, and target protein. There
are approximately ten members in the family, including cathepsin D, cathepsin E, and
pepsin. Additionally, a new member of the family, nothepsin, which shares some
characteristics with cathepsin D and cathepsin E, was first identified in the liver of
Antarctic Notothenioidei (Capasso et al. 1998), and subsequently isolated in zebra
fish (Riggio et al. 2001) and lizard (Borrelli et al. 2006). The nothepsin in zebra fish
was exclusively expressed in the liver (Riggio et al. 2001), and was processed in an
oestrogen-induced expression manner (Riggio et al. 2002). In lizards, nothepsin was
constitutively expressed in both males and females (Borrelli et al. 2006). By
screening public databases for nothepsin-like sequences in organisms other than fish
and lizards, nothepsin-like proteins were absent in other tetrapods, with the exception
of a pseudo gene (“similar to nothepsin”) identified in the genome of Gallus gallus
(Borrelli et al. 2006). However, two independent proteomic studies on the chicken
egg yolks revealed the presence of a “similar to nothepsin” protein, also named
cathepsin E-A-like, which was encoded by a nothepsin-like gene (Mann & Mann
2008; Farinazzo et al. 2009). This suggested that, cathepsin E-A-like, the so-called
pseudo gene in chicken, actually encoded a functional protein. Expression profile
studies have revealed that the “similar to nothepsin” protein is only expressed in the
liver of female chicken, as is the case for nothepsin in zebra fish. Furthermore, its
expression level was gradually increased during sexual maturation (Bourin et al.
2012a). These observations suggest that the expression of cathepsin E-A-like is
regulated by the steroid environment of laying hens, but the exact mechanism is
unknown.
Recently, we obtained the chicken liver transcriptome sequencing data by using
the RNA-seq technique to investigate the mechanism of hepatic lipid metabolism (Li
et al. 2015). A significantly up-regulated uncharacterized protein coding gene,
predicted to be cathepsin E-A-like gene was found in the liver of egg-laying hen. To
determine the biological functions of cathepsin E-A-like in chicken, we cloned and
sequenced the gene and analysed its counterparts among different species.
Additionally, we evaluated the expression regulation mechanism of the gene in vivo
and in vitro. Our results demonstrated that cathepsin E-A-like shared the same
evolutionary origin with nothepsin, and the regulation of estrogen on its expression in
chicken liver was predominantly mediated by estrogen receptor β (ERβ).
Materials and methods
Animals and sampling
The birds used in the study were Hy-Line White laying hens. They were raised in cages
and maintained under a 12 h light/dark cycle and 25-28 °C with ad libitum water and food.
All the experimental procedures were approved by the Institutional Animal Ethics
Committee of Henan Agricultural University (Permit Number: 11-0085).
To clone the cathepsin E-A-like gene and investigate the effect of estrogen on expression
of the gene, a total of 80 female birds (10 weeks old) were randomly divided into 4 groups
(20 birds/group). The birds in groups 1, 2, and 3 were intramuscularly injected under the left
wings with 0.5, 2.0, and 8.0 mg/kg body weight of 17β-estradiol (Sigma-Aldrich, St. Louis,
MO, USA) dissolved in olive oil, respectively. The birds in group 4 were used as the control,
and were intramuscularly injected under the left wing with olive oil only. Ten birds from
each group were slaughtered at 6 or 12 h after injection. Livers were collected quickly,
snop-frozen in liquid nitrogen, and then stored at −80C until use.
Culture of primary hepatocytes
Fertilized specific pathogen free chicken eggs were purchased from Beijing
Meiliyaweitong Experimental Animal Technology Co. Ltd (Beijing, China), and incubated at
38°C with a relative humidity of 65%. When the eggs were incubated for 18 days, the
hepatocytes were isolated from the embryonic liver following the method previously
described (Kennedy et al. 1993) with some modifications. In brief, livers were removed from
18-day-old embryos under sterile conditions, and then washed with D-Hanks solution
(Solarbio, Beijing, China). The liver was aseptically minced into small fragments, washed
with D-Hanks solution, and digested by 0.1% collagenase IV (Sigma-Aldrich) in D-Hanks
solution (Solarbio) in a shaking water bath at 35°C. After digestion for 20-30 min with
frequent pipetting to facilitate cell dissociation, the dispersed cells were filtered through 200-
and 500-meshsieves and collected by centrifugation twice at 100×g for 5 min at room
temperature. The cells were resuspended with Williams’ medium (Sigma-Aldrich),
transferred on top of Percoll (density: 1.10 g/mL) and centrifuged at 100×g for 5 min at
room temperature. Then the cells were resuspended in fresh Williams medium supplemented
with 100 mg/mL streptomycin, 100 U/mL penicillin, and 10% fetal calf serum (basal
medium), and counted using a Luna automated cell counter (Biosystems L10001,Gyeonggi,
Korea). The cell viability was greater than 90% as assessed by the trypan blue exclusion
assay. Cells were seeded in collagen-coated 6-well plates at a density of 1 × 106 cells/well in
2 mL final volume. Cells were incubated in incubator at 38.5 °C under a saturated humidity
atmosphere containing 95% air and 5% CO2.
Stimulation of cultured primary hepatocytes
The 17β-estradiol was dissolved in ethanol, and different types estrogen receptor
antagonists including MPP (1, 3-bis (4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)
phenol]-1H-pyrazoledihydrochloride), ICI 182,780 and tamoxifen (Sigma-Aldrich) were
dissolved in DMSO. The MPP is a highly selective antagonist of ER-alpha. The ICI 182,780
and tamoxifen are antagonists of both ERα and ERβ, but may also act as the agonists of
GPR30 on certain genes in some species (Guo et al. 2006; Pang et al. 2008). After the cells
were cultured for 24 hours, the basal medium was replaced with fresh serum-free Williams’
medium supplemented with 100 mg/mL streptomycin, 100 U/mL penicillin, and then
incubated for 6 h.
To distinguish the specific estrogen receptor subtypes that delivered the estrogen effect,
the cells were stimulated with 100 nM of 17β-estradiol alone or combined with 1 μM of MPP,
1 μM of ICI 182,780, or 1 μM of tamoxifen with six replicates in each treatment group. The
control group received ethanol and DMSO at a final concentration of 0.1% each. The cells
were collected after treatment for 24 h, and stored at -80 °C until use.
RNA extraction and cDNA synthesis
Total RNA was extracted from the tissues and cells using RNAiso Plus reagent (Takara,
Dalian, China) according to the manufacturer's instructions, respectively. The integrity of
total RNA was confirmed by gel electrophoresis, and the concentration was determined using
a NanoDrop2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The
RNA was then reversely transcribed using a PrimeScriptTM RT Reagent kit with gDNA
Eraser (Takara) according to the manufacturer's instructions.
Cloning and sequencing of PCR products
According to the predicted Gallus gallus cathepsin E-A-like sequence published in
GenBank (accession no. NM_001318427.1), two pairs of specific PCR primers (Table 1)
used for cloning the coding sequence (CDs) region of the gene were designed using the
software Primer 5.0. The PCR was performed in a 50 µL reaction volume containing 2 µL of
first strand cDNA, 25 µL of 2 × pfu MasterMix (TiangenBiotech Co. Ltd., Beijing, China),
2.5 µL each of forward and reverse primers (10 µM), 18 µL deionized water. The reaction
conditions were 94 °C for 5 min, 30 cycles at 94 °C for 30 s, 60 °C for 30 s, and 72 °C for 30
s, followed by 72 °C for 10 min. The PCR products were sequenced by Sangon Biotech Co.
Ltd. (Shanghai, China) and Beijing Genomics Institute (Beijing, China). Each PCR product
was sequenced twice from both directions by using DNA sequencing on an ABI3730XL
DNA analyzer (Applied Biosystems, Foster City, California, USA).
Phylogenetic and syntenic analysis
The sequences used for phylogenetic and syntenic analysis were retrieved from the
genomic data bank using the Basic Local Alignment Search Tool (BLAST) homology search.
The Cathepsin E-A-like, Cathepsin E, Cathepsin D and nothepsin nucleotide sequences
alignments were performed by using clustal W (Thompson et al. 1994). Alignments were
also adjusted manually to guarantee correct reading frames. Non-coding sequences were
removed before alignment. Phylogenetic analysis was conducted using two different methods.
The Bayesian method was implemented in the software MrBayes3.1 (John et al. 2001). The
evolutionary model was set to the general-time-reversible model with a proportion of
invariant sites and discrete gamma model. The analysis was run until the standard deviation
of split frequencies reached a value below 0.01 (i.e. after 2,000,000generations) with a
sampling every 100 generations. The neighbour-joining method was implemented in the
software MEGA6.0 (Tamura et al. 2013). The evolutionary model was set to the Tamura
3-parameter model with a proportion of invariant sites and discrete gamma model
implemented in paup* 4.0b10.0 (Swofford 2003). Evaluation of statistical confidence in
nodes was based on 2000 bootstrap replicates. Branches with <50 % bootstrap value were
collapsed.
Synteny maps of the conserved genomic regions in human, mouse, chicken, mallard,
turtle, xenopus, coelacanth, zebra fish, and torafugu were obtained using PhyloView in
Genomicus v84.01 (Louis et al. 2014) available at http://www.genomicus.biologie.ens.fr/-
genomicus-84.01/cgi-bin/search.pl.
Promoter and ER-dependent elements prediction
The potential promoter of cathepsin E-A-like in 5’ flanking region was predicted by
using two online softwares including PROSCAN (Dan 1995)
(http://www-bimas.cit.nih.gov/molbio/proscan/) and Promoter 2.0 (Knudsen 1999)
(http://www.cbs.dtu.dk/services/Promoter). ER-dependent elements (estrogen response
elements (ERE) and AP1 response elements) were predicted by using TRANSFAC
non-professional version: http://www.gene-regulation.com/index2.
Quantitative Real Time-PCR (qPCR)
The qPCR was performed on the LightCycler® 96 real time PCR system (Roche Applied
Science, Penzberg, Germany) in a 10 μL reaction volume containing 1µL cDNA, 5 µL of 2 ×
SYBR®Premix Ex TaqTM II (TliRNaseH Plus) from TaKaRa, 0.5 µL each of forward and
reverse primers (10 µM), and 3 µL RNase free water. The qPCR amplification procedure was
as following, pre-incubation at 95 °C for 3 min, and followed by 40 cycles of 95 °C for 10 s,
60 °C for 30 s, and 72 °C for 30 s. All reactions were run in triplicates.
Statistical Analysis
The relative level of each mRNA was normalized to the β-actin and analysed by using
the 2−ΔΔct method (Schmittgen & Livak 2008). Statistical analyses of the qPCR results were
conducted using SPSS 21.0 (IBM Corp., Armonk, NY, USA). A one-way analysis of
variance test and repeated measure analysis of variance test were used to compare relative
expression levels followed by a Dunnett’s test using Graphpad Prism 5 (Graphpad Software,
San Diego, CA, USA). Differences were considered significant at P ≤ 0.05. Datas were
expressed as the mean ± SD.
Results
Cloning and sequence analysis of chicken cathepsin E-A-like gene
The coding sequence of chicken cathepsin E-A-like gene were cloned from the liver
tissue of chicken by using the two pairs of primers (Table 1) and sequenced by direct
sequencing of PCR products. Comparison analysis of chicken cathepsin E-A-like sequence
with chicken cathepsin D and cathepsin E revealed 45% and 49% identity at the amino acid
level, respectively. Cathepsin E-A-like contained two conserved typical eukaryotic and viral
aspartyl protease active signatures, as do other aspartyl proteases (Fig. 1).
Phylogenetic analysis
Amino acid sequences of cathepsin D, cathepsin E, and cathepsin E-A-like from
different species were retrieved from GenBank. The accession number for each gene in
different species were list in Table 2. Based on alignment of the 28 nucleotide sequences,
phylogenetic trees were generated by the neighbour-joining method (Fig. 2 A) and Bayesian
method (Fig. 2 B), respectively. Both of the phylogenetic trees indicated that all the
sequences were clustered into three clades, cathepsin D, cathepsin E, and cathepsin
E-A-like/nothepsin.
Syntenic analysis of cathepsin E-A-like gene
To further understand the evolutionary history of cathepsin E-A-like gene in the
sauropsid lineage, a syntenic analysis of the cathepsin E-A-like neighbouring genes in
representative sauropsid genomes was performed. The cathepsin E-A-like gene in chicken,
mallard, turtle, xenopus, and coelacanth was positioned in genomic regions containing
uniformly arranged common genes including MYRFL, RAB3IP, BEST3, LRRC10, CCT,
FRS2, and YEATS4, and the detailed genomic locations of these genes were given in Table 3.
The nothepsin gene in zebra fish and torafugu might also be positioned in the same region,
though it appears that some genes in the region were not mapped or were lost (Fig. 3).
Effect of estrogen on the expression of cathepsin E-A-like gene in juvenile hens
To investigate whether the expression of chicken hepatic cathepsin E-A-like was
dependent on estrogen, female pullets (10 weeks old) were treated with different doses of
17β-estradiol. The expression of ApoVLDLⅡ was provided to be a positive control as
17β-estradiol could significantly induce ApoVLDLⅡ expression (Hermann et al. 2003). The
expression of cathepsin E-A-like was significantly increased in a dosage dependent manner
after 6h or 12h treatment with 17β-estradiol (P < 0.05) (Fig. 4A), as did the expression of
ApoVLDLⅡ (P < 0.05) (Fig. 4B).
Promoter and ER-dependent elements prediction of cathepsin E-A-like
Generally, transcription factors regulate gene expression by directly or indirectly
combining its specific elements within the promoter region of the gene. We herein predicted
the potential promoter region of cathepsin E-A-like and the ER-dependent elements within
the promoter region. The predicted results showed that there could exist transcription activity
region of promoter nearby -346bp and -2047bp (Table 4). Meanwhile, a classical ERE
(GGTCAnnnTGACC), two non-classical EREs, and three AP1 response elements were
found near the potential promoter by TRANSFAC non-professional version:
http://www.gene-regulation.com/index2 (Table 5), which supported the hypothesis that
estrogen stimulates expression of chicken cathepsin E-A-like through ER.
Effects of ER subtype antagonists on the expression of cathepsin E-A-like gene
To further understand which ER subtype of estrogen mediates the expression of
cathepsin E-A-like gene, primary hepatocytes were treated with 17β-estradiol alone or
combined with different ER subtype antagonists. Compared with the control group, the
expression of cathepsin E-A-like was significantly increased when the hepatocytes were
treated with 100 nM 17β-estradiol alone or 100nM 17β-estradiol combined with 1μM MPP
(P < 0.05). Compared with the 17β-estradiol treatment group, the expression of cathepsin
E-A-like was significantly decreased (P < 0.05) when the hepatocytes were treated with 100
nM 17β-estradiol combined with 1 μM tamoxifen or 1 μM ICI 182,780 (Fig. 5). Because
MPP acts as a highly selective antagonist to ER-α, whereas tamoxifen and ICI 182,780
antagonize all nuclear ERs, the results indicated that the regulation of estrogen on the
expression of chicken hepatic cathepsin E-A-like was mediated via ER-β.
Discussion
Evolutionary and functional analysis of cathepsin E-A-like
Aspartic proteinases are proteolytic enzymes that are generally activated under acidic
conditions to accomplish their catalytic function (Benes et al. 2008). The enzymes are
characterized by two structure similar domains positioned in the middle of the molecules
(Sepulveda et al. 1975). This suggests that the genes encoding the enzymes evolved through
gene duplication (Tang et al. 1978). The cathepsin E-A-like, also known as “similar to
nothepsin” in chickens, is a new member of the aspartic proteinase family that shares the
sequence and structure similarity with cathepsin D (Mann & Mann 2008; Bourin et al. 2012b)
and cathepsin E. These observations are consistent with results of previous studies on
nothepsin, cathepsin D, and cathepsin E (Capasso et al. 1998). Interestingly, molecular
evolutionary evidence has supported the view that nothepsin was lost in higher vertebrates
such as avian and mammals during the process of evolution, and only presented in lower
vertebrates including fish (Borrelli et al. 2006). Our study suggested that cathepsin E-A-like
was an orthologous gene with nothepsin, which was presented in birds but lost in mammals.
Cathepsin D and cathepsin E are two important members of the aspartic proteinase
family. They are intracellular enzymes localized in the lysosomal compartment. Cathepsin D
was found existing in almost all cells and tissues, and took part in several physiological
functions, including protein degradation, apoptosis, and autophagy in mammals (Benes et al.
2008; Zaidi et al. 2008). In chicken, most egg-yolk precursors, such as very-low-density
lipoprotein and vitellogenin, are transferred into growing chicken oocytes by
receptor-mediated endocytosis. The protein moieties of these lipoproteins are further
proteolytically cleaved in the oocytes by cathepsin D. The resulting polypeptides are stored
in the yolk compartments for subsequent utilization by the embryo during development (Shen
et al. 1993; Elkin et al. 1995; Gerhartz et al. 1999; Bourin et al. 2012a; Bourin et al. 2012b).
However, cathepsin did not appear to be present in egg yolk based on proteomic analysis
(Mann & Mann 2008; Farinazzo et al. 2009), though tracing amounts of cathepsin D bound
to pepstatin-sepharose. It has been suggested that chicken cathepsin D may play a role in the
early stage of yolk formation (Bourin et al. 2012a) and influence yolk traits (Sheng et al.
2013), but may be not involved in embryonic growth and development. Indeed, studies with
cathepsin D knock-out mice have revealed that cathepsin D was not necessary for embryonic
development, but was necessary for postnatal tissue homeostasis (Benes et al. 2008).
Consistent with previous studies (Bourin et al. 2012a; Bourin et al. 2012b), cathepsin
E-A-like gene was specifically expressed in the female chicken liver and up-regulated during
sexual maturation. More importantly, unlike cathepsin D, cathepsin E-A-like could also be
detected in egg yolk (Mann & Mann 2008; Farinazzo et al. 2009). Evidence accumulated to
date implied that cathepsin E-A-like protein as the aspartic protease is likely to involve in the
processing of egg yolk protein, and may play an indispensable role in embryonic
development of chicken.
Estrogen regulation pathway of cathepsin E-A-like
In chicken, the up-regulated expression of cathepsin E-A-like in liver during maturation
suggested that the gene may be induced by sex steroids (Bourin et al. 2012b). In our study,
treatment with different doses of 17β-estradiol in 10-week-old pullets clearly demonstrated
that cathepsin E-A-like expression could be induced and up-regulated in a dosage dependent
manner by estrogen, which was consistent with prior studies showing that the expression of
nothepsin in the liver of male zebra fish increased after estrogen treatment (Riggio et al.
2002).
Estrogen stimulates gene expression by binding its receptors including nuclear receptors
(ER-α and ER-β) (Jensen & Desombre 1973; Greene G.L. 1986; Kuiper G.G. 1996; Hewitt
& Korach 2003; Koehler et al. 2005) and membrane receptor (a G protein-coupled receptor,
GPR30 (Makino & Schmid-Schönbein 2006). A classical ERE, two non-classical EREs, and
three AP1 response elements were found near the potential promoter of chicken cathepsin
E-A-like gene. This prompted us that chicken cathepsin E-A-like might be induced to
transcribe by the compound of estrogen-estrogen nuclear receptors binding ERE or AP1
response elements.
To confirm the effect of estrogen receptor transduction pathway on the expression of
cathepsin E-A-like, the specific antagonists of estrogen receptors were used.
Co-administration of 17β-estradiol with MPP, a highly selective antagonist for ER-α, in
primary cultured embryonic female hepatocytes did not suppress the expression of cathepsin
E-A-like. This indicated that the estrogen didn’t play its role via ER-α. In contrast, the
expression level of cathepsin E-A-like was significantly reduced by co-administration of
17β-estradiol with antagonist of all nuclear ERs either ICI 182,780 or tamoxifen to
hepatocytes. It suggested that the expression of cathepsin E-A-like in chicken liver was most
likely mediated by estrogen through binding ER-β. Additionally, previous study had also
found that both ICI 182,780 and tamoxifen acted as the agonists of GPR30 (Pang et al. 2008),
and could play a role in mediating the effects of 17β-estradiol on the expression of certain
genes (Guo et al. 2006). Moreover, tamoxifen could potentially activate the transcription of
genes which under the control of an AP1 element (Webb et al. 1995). However, cathepsin
E-A-like was not trans activated by co-administration of 17β-estradiol with either tamoxifen
or ICI 182,780 to hepatocytes. Therefore, the results excluded that the involvement of
GPR30 and AP1 element in activating the expression of cathepsin E-A-like.
In summary, cathepsin E-A-like was an orthologous gene with nothepsin, which was
presented in birds but lost in mammals. The regulation of estrogen on the expression of
cathepsin E-A like mRNAs was predominantly mediated by ER-β in the liver of chicken.
Acknowledgments
This research was supported by the Key Science and Technology Research of Henan
Province (No.151100110800), Rolling Support Project for Innovation Research Team of
Ministry of Education (No.IRT16R23), and the International Cooperation Project of Henan,
China (No.162102410030).
Author contributions
ZH and LH performed the experiments, analyzed the data, and wrote the manuscript. TW and
XC participated in the management of the experimental animals and contributed to the qPCR
analyses. JL and WD participated in the sample collection, RNA isolation and contributed to
the qPCR analyses. LZ and SG participated in the management of the experimental animals.
KX and YF participated in the experiment design and discussion. LX conceived the study
and wrote the manuscript. All authors have read and approved the final manuscript.
References
Benes P., Vetvicka V. & Fusek M. 2008 Cathepsin D--many functions of one aspartic protease.
Crit Rev in Oncol hema.68, 12-28.
Bohley P. & Seglen P.O. 1992 Proteases and proteolysis in the lysosome. Experientia.48, 151-7.
Borrelli L., De Stasio R., Filosa S., Parisi E., Riggio M., Scudiero R. & Trinchella F. 2006
Evolutionary fate of duplicate genes encoding aspartic proteinases. Nothepsin case study.
Gene.368, 101-9.
Bourin M., Gautron J., Berges M., Hennequet-Antier C., Cabau C., Nys Y. & Réhault-Godbert S.
2012a Transcriptomic profiling of proteases and antiproteases in the liver of sexually
mature hens in relation to vitellogenesis. Bmc Genomics.13, 457.
Bourin M., Gautron J., Berges M., Nys Y. & Réhaultgodbert S. 2012b Sex- and tissue-specific
expression of "similar to nothepsin" and cathepsin D in relation to egg yolk formation in
Gallus gallus. Poultry Sci.91, 2288-93.
Brady L., Romsos D.R. & Leveille G.A. 1976 In vivo estimation of fatty acid synthesis in the
chicken ( Gallus domesticus) utilizing 3H2O. Com Biochem Phys B.54, 403-7.
Capasso C., Riggio M., Scudiero R., Carginale V., Di P.G., Kay J., Kille P. & Parisi E. 1998
Molecular cloning and sequence determination of a novel aspartic proteinase from
Antarctic fish. Biochimica Et Biophysica Acta.1387, 457-61.
Carnevali O., Cionna C., Tosti L., Lubzens E. & Maradonna F. 2006 Role of cathepsins in ovarian
follicle growth and maturation. Gen Comp Endocr.146, 195-203.
Dan S.P. 1995 Predicting Pol II Promoter Sequences using Transcription Factor Binding Sites. J
Mol Biol.249, 923-32.
Elkin R.G., Freed M.B., Danetz S.A.H. & Bidwell C.A. 1995 Proteolysis of Japanese quail and
chicken plasma apolipoprotein B and vitellogenin by cathepsin D: Similarity of the
resulting protein fragments with egg yolk polypeptides. Com Biochem Phys B. 112,
191-6.
Farinazzo A., Restuccia U., Bachi A. & Pier Giorgio R. 2009 Chicken egg yolk cytoplasmic
proteome, mined via combinatorial peptide ligand libraries. J Chromatogr A.1216,
1241-52.
Gerhartz B., Kolb H.J. & Wittmann J. 1999 Proteolytic activity in the yolk sac membrane of quail
eggs. Com Biochem Phys A. 123, 1-8.
Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y. & Shine J. 1986 Sequence and Expression
of Human Estrogen Receptor Complementary DNA. Science.231, 1150-4.
Guo R.X., Wei L.H., Zhao D., Wang J.L. & Xiao-Ping L.I. 2006 Effects of ICI182780 (Faslodex) on
proliferation and apoptosis induced by 17β-estradiol in endometrial carcinoma cells. Journal
of Peking University.38, 470-474.
Hermann M., Foisner R., Schneider W.J. & Ivessa N.E. 2003 Regulation by estrogen of synthesis
and secretion of apolipoprotein AI in the chicken hepatoma cell line, LMH-2A. BBA-Mol
Cell Res.1641, 25-33.
Hewitt S.C. & Korach K.S. 2003 Oestrogen receptor knockout mice: roles for oestrogen receptors
alpha and beta in reproductive tissues. Reproduction125, 143-9.
Jensen E.V. & Desombre E.R. 1973 Estrogen-receptor interaction. Science.182, 126-34.
John P., Huelsenbeck P., Ronquist F., John M., Huelsenbeck P., Ronquist F. & Hall B. 2001
MrBayes: A program for the Bayesian inference of phylogeny. Bioinformatics.
Kennedy S.W., Lorenzen A., James C.A. & Collins B.T. 1993 Ethoxyresorufin- O -deethylase and
Porphyrin Analysis in Chicken Embryo Hepatocyte Cultures with a Fluorescence
Multiwell Plate Reader. Anal Biochem.211, 102-12.
Knudsen S. 1999 Promoter2.0: for the recognition of PolII promoter sequences.
Bioinformatics.15, 356-61.
Koehler K.F., Helguero L.A., Haldosén L.A., Warner M. & Gustafsson J.A. 2005 Reflections on
the discovery and significance of estrogen receptor beta. Endocr Rev.26, 465-78.
Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S. & Gustafsson J.A. 1996 Cloning of a novel
receptor expressed in rat prostate and ovary. P Natl Acad Sci USA.93, 5925-30.
Li H., Wang T., Xu C., Wang D., Ren J., Li Y., Tian Y., Wang Y., Jiao Y. & Kang X. 2015
Transcriptome profile of liver at different physiological stages reveals potential mode for
lipid metabolism in laying hens. Bmc Genomics16, 1-13.
Louis A., Nguyen N.T.T., Muffato M. & Crollius H.R. 2014 Genomicus update 2015: KaryoView
and MatrixView provide a genome-wide perspective to multispecies comparative
genomics. Nucleic Acids Res. 43, 682-9.
Makino A., Prossnitz E.R., Bunemann M., Wang J.M., Yao W. & Schmid-Schonbein G.W. 2006 G
protein-coupled receptors serve as mechanosensors for fluid shear stress in neutrophils.
Am J Physiol Cell Physiol.290, C1633-9.
Mann K. & Mann M. 2008 The chicken egg yolk plasma and granule proteomes. Proteomics.8,
178-91.
Nikolay B., Plieschnig J.A., Šubik D., Schneider J.D., Schneider W.J. & Hermann M. 2013 A
novel estrogen-regulated avian apolipoprotein. Biochimie.95, 2445-53.
Pang Y., Dong J. & Thomas P. 2008 Estrogen signaling characteristics of Atlantic croaker G
protein-coupled receptor 30 (GPR30) and evidence it is involved in maintenance of
oocyte meiotic arrest. Endocrinology.149, 3410-26.
Rao K.V.R. & Kielian T. 2015 Astrocytes and Lysosomal Storage Diseases.
Neuroscience.323:195-206.
Retzek H., Steyrer E., Sanders E.J., Nimpf J. & Schneider W.J. 1992 Molecular cloning and
functional characterization of chicken cathepsin D, a key enzyme for yolk formation.
Dna Cell Biol.11, 661-72.
Riggio M., Scudiero R., Filosa S. & Parisi E. 2001 Sex- and tissue-specific expression of aspartic
proteinases in Danio rerio (zebrafish). Gene.260, 67-75.
Riggio M., Scudiero R., Filosa S. & Parisi E. 2002 Oestrogen-induced expression of a novel
liver-specific aspartic proteinase in Danio rerio (zebrafish). Gene.295, 241-6.
Schmittgen T.D. & Livak K.J. 2008 Analyzing real-time PCR data by the comparative C(T)
method. Nat Protoc.3, 1101-8.
Sepulveda P., Jr M.J., Liu D. & Tang J. 1975 Primary structure of porcine pepsin. III. Amino acid
sequence of a cyanogen bromide fragment, CB2A, and the complete structure of porcine
pepsin. J Biol Chem.250, 5082-8.
Shen X., Steyrer E., Retzek H., Sanders E.J. & Schneider W.J. 1993 Chicken oocyte growth:
receptor-mediated yolk deposition. Cell & Tissue Res.272, 459-71.
Sheng Q., Cao D., Zhou Y., Lei Q., Han H., Li F., Lu Y. & Wang C. 2013 Detection of SNPs in
the Cathepsin D Gene and Their Association with Yolk Traits in Chickens. Plos One.
8,e56656.
Swofford D.L. PAUP. 2003 Phylogenetic analysis using parsimony (and other methods), Version
4, Sinauer Associates. Sunderland, MA, USA.
Tamura K., Stecher G., Peterson D., Filipski A. & Kumar S. 2013 MEGA6: Molecular
Evolutionary Genetics Analysis version 6.0. Mol Biol Evol.30, 2725-9.
Tang J., James M.N., Hsu I.N., Jenkins J.A. & Blundell T.L. 1978 Structural evidence for gene
duplication in the evolution of the acid proteases. Nature.271, 618-21.
Thompson J.D., Higgins D.G. & Gibson T.J. 1994 CLUSTAL W (improving the sensitivity of
progressive multiple sequence alignment through sequence weighting, position-specific
gap penalties and weight matrix choice). Nucleic Acids Res. 22, 4673–80.
Walzem R.L., Hansen R.J., Williams D.L. & Hamilton R.L. 1999 Estrogen induction of VLDLy
assembly in egg-laying hens. J Nutr.129, 467S-72S.
Webb P., Lopez G.N., Uht R.M. & Kushner P.J. 1995 Tamoxifen activation of the estrogen
receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of
antiestrogens. Mol Endocrinol.9, 443-56.
Winchester B. 2014 Lysosomal diseases: diagnostic update. J Inherit Metab Dis.37, 599-608.
Wiskocil R., Bensky P., Dower W., Goldberger R.F., Gordon J.I. & Deeley R.G. 1980 Coordinate
regulation of two estrogen-dependent genes in avian liver. P Natl Acad Sci USA.77,
4474-8.
Zaidi N., Maurer A., Nieke S. & Kalbacher H. 2008 Cathepsin D: A cellular roadmap. Biochem
Bioph Res C.376, 5-9.
Tables
Table 1 The primers used for PCR and qPCR
Primers name Sequence (5'-3')
Clone primer 1 F:TGATTGATTGACCTGGCGAG
R:ATTCTCAGTGTCGTCTCCCC
Clone primer 2 F:GTTACCCCTCCCTAGCAGTG
R:ACCGAACTGTATAATCTGGGACA
cathepsin E-A-like F:TTCATATGAGCACGGTGGGG
R:GGTCATTCCTGGCTCAAACA
β-actin F:CAGCCAGCCATGGATGATGA
R:ACCAACCATCACACCCTGAT
ApoVLDLⅡ F:CAATGAAACGGCTAGACTCA
R:AACACCGACTTTTCTTCCAA
Note: F refers to forward primer, R refers to reverse primer; both clone primer 1 and 2 were
used to clone the different fragments of cathepsin E-A-like coding; primers for cathepsin
E-A-like,β-actin and ApoVLDLⅡ were used for qPCR.
Table 2 The accession number of genes in different species selected for constructing
the phylogenetic tree
Species Gene Symbol GenBank Access No.
Homo sapiens (human) cathepsin E NM_001910.3
cathepsin D NM_001909.4
Mus musculus (House mouse) cathepsin E NM_007799.3
cathepsin D X52886.1
Gallus (Chicken) cathepsin E-A-like NM_001318427.1
cathepsin E XM_015299070.1
cathepsin D NM_205177.1
Anas platyrhynchos (Mallard Duck) cathepsin E-A-like XM_013097234.1
cathepsin E XM_013092198.1
cathepsin D XM_005019737.2
Chrysemyspicta (Painted Turtle) cathepsin E-A-like XM_005280047.2
cathepsin E XM_005306437.1
cathepsin D XM_005307767.2
Alligator mississippiensis (Alligator) cathepsin E-A-like XM_006275048.1
cathepsin E XM_006267822.2
cathepsin D XM_006274391.2
Xenopus tropicalis (Xenopus) cathepsin E-A-like XM_002938510.2
cathepsin E NM_001126997.1
cathepsin D BC075272.1
Latimeriachalumnae (Coelacanth) cathepsin E-A-like XM_006006586.2
cathepsin E XM_006000395.1
cathepsin D XM_014493564.1
Danio rerio (Zebrafish) cathepsin D AJ278268.1
nothepsin NM_131804.1
Podarcissicula (Italian wall Lizard) cathepsin D AJ009838
nothepsin AJ876601
Trematomus Bernacchii nothepsin Y08567
Takifugurubripes ( Fugu Rubripe) nothepsin AB179551
Table 3 The detail genomic locations of cathepsin E-A-like/nothepsin genes and neighbouring
genes among different species
Species Gene symbol Chromosome location Start End
Human Cathepsin E-A-like / / /
Nothepsin / / /
MYRFL 12 69824569 69958724
RAB31P 12 69738400 69823204
BEST3 12 69643508 69699416
LRRC10 12 69608564 69611162
CCT2 12 69585428 69601577
FRS2 12 69470349 69579793
YEATS4 12 69359700 69424838
Mouse Cathepsin E-A-like / / /
Nothepsin / / /
MYRFL 10 116776545 116896879
RAB31P 10 116905780 116950448
BEST3 10 116986314 117025687
LRRC10 10 117045341 117046768
CCT2 10 117050997 117063814
FRS2 10 117070127 117148474
YEATS4 10 117215141 117224507
Chicken Cathepsin E-A-like 1 35,522,108 35,530,565
Nothepsin / / /
MYRFL 1 35596745 35639816
RAB31P 1 35565026 35594366
BEST3 1 35534374 35554698
LRRC10 1 35517128 35519048
CCT2 1 35503983 35515944
FRS2 1 35447938 35501010
YEATS4 1 35429810 35432580
Mallard Duck Cathepsin E-A-like Unplaced Scaffold 155,763 163,871
Nothepsin / / /
MYRFL Unplaced Scaffold 43846 88828
RAB31P Unplaced Scaffold 91691 120644
BEST3 Unplaced Scaffold 120672 154519
LRRC10 Unplaced Scaffold 169228 170200
CCT2 Unplaced Scaffold 172363 189740
FRS2 Unplaced Scaffold 190611 232396
YEATS4 Unplaced Scaffold 260531 265649
Painted Turtle Cathepsin E-A-like Unplaced Scaffold 1,771,646 1,806,546
Nothepsin / / /
MYRFL Unplaced Scaffold 1931363 1985401
RAB31P Unplaced Scaffold 1866924 1935457
BEST3 Unplaced Scaffold 1814235 1846102
LRRC10 Unplaced Scaffold 1761474 1763026
CCT2 Unplaced Scaffold 1719446 1747101
FRS2 Unplaced Scaffold 1615810 1703260
YEATS4 Unplaced Scaffold 1568395 1577579
Xenopus Cathepsin E-A-like Unplaced Scaffold 87,745,910 87,754,872
Nothepsin / / /
MYRFL Unplaced Scaffold 87828561 87898611
RAB31P Unplaced Scaffold 87784996 87817071
BEST3 Unplaced Scaffold 87758824 87785071
LRRC10 Unplaced Scaffold 87737507 87740937
CCT2 Unplaced Scaffold 87723580 87737677
FRS2 Unplaced Scaffold 87683138 87718029
YEATS4 Unplaced Scaffold 87496454 87503104
Coelacanth Cathepsin E-A-like Unplaced Scaffold 125,630 143,779
Nothepsin / / /
MYRFL / / /
RAB31P Unplaced Scaffold 5695 28404
BEST3 Unplaced Scaffold 84922 119110
LRRC10 Unplaced Scaffold 149270 150460
CCT2 Unplaced Scaffold 156539 187893
FRS2 Unplaced Scaffold 210570 220445
YEATS4 Unplaced Scaffold 303693 318698
Zebrafish Cathepsin E-A-like / / /
Nothepsin Unplaced Scaffold 6,656 16,932
MYRFL 4 71140271 71193475
RAB3IP 4 71068603 71127426
BEST3 / / /
LRRC10 / / /
CCT2 4 76623606 76624991
FRS2 / / /
YEATS4 / / /
Torafugu Cathepsin E-A-like / / /
Nothepsin Unplaced Scaffold 22,780 25,185
MYRFL Unplaced Scaffold 10366 15005
RAB31P / / /
BEST3 Unplaced Scaffold 25683 30714
LRRC10 / / /
CCT2 Unplaced Scaffold 18659 22442
FRS2 / / /
YEATS4 / / /
Table 4 Prediction of the cathepsin E-A-like promoter region
Programs Promoter position Comments
Promoter 2.0 -2047 Promoter Score: 0.597 (promoter cutoff: 0.50)
-346 Promoter Score: 1.217 (promoter cutoff: 0.50)
PROSCAN / /
Note: Translation start site (TSS) was defined as +1; the upstream of TSS was indicated with
minus number.
Table 5 Prediction of the ER-dependent response elements in the promoter region of
cathepsin E-A-like gene
Response elements Element Position Identifier sequence Binding Factor
Classical ERE
(GGTCAnnnTGACC)a
-986 AGGTCA ER-alpha, ER-beta1
Non-classical ERE -388 TGACCT ER-alpha, ER-beta1
-506 TGACCT ER-alpha, ER-beta1
AP1 -822 TGAGTCA AP-1, c-Fos, c-Jun
-1824 TGACTCA AP-1, c-Fos, c-Jun
-1832 TGACTCT AP-1, c-Fos, c-Jun
Note: The search criteria: Minimum length sites 6, Maximum number of mismatches 0,
Mismatch penalty 100, Boundary score 100; a means the classical ERE binding site, n
represents any base.
Figure captions
Fig. 1. Amino acid sequence alignment of chicken cathepsin D, cathepsin E-A-like and
cathepsin E. CTSD: cathepsin D (GenBank: NP_990508.1); CTSEL: cathepsin E-A-like
(GenBank: NP_001305356.1); CTSE: cathepsin E (GenBank: XP_015154556.1). Identical
and homologous residues are marked with a black and gray background. The signal peptide
and two aspartate active sites are denoted above the alignment. The two conserved cysteines
are indicated by black arrowheads.
Fig. 2. Phylogenetic relationship among cathepsin D, cathepsin E, nothepsin, and cathepsin
E-A-like in vertebrate. (A) The phylogenetic tree produced by using the Neighbour joining
method; (B) The phylogenetic tree produced by using the Bayesian method. The accession
numbers of gene in different species used to construct the phylogenetic tree are shown in the
table (Table 2).
Fig. 3. Genome conservation of synteny comparison between cathepsin E-A-like/nothepsin
and the neighbouring genes among different species. Chr.un indicates an unknown
chromosome. The species were listed on the left of the chromosomes. The gene symbols are
listed on the top. The genes indicated by different color boxes in the same column means
existing in the according species. The Cathepsin E-A-like gene are highlighted using the red
boxes. The dotted red boxes refer to nothepsin gene. The tip direction of the different genes
boxes means the transcription direction. The detailed genomic locations of genes are listed in
Table 2.
Fig. 4. Effects of 17β-estradiol on the expression of cathepsin E-A-like (A), and ApoVLDLⅡ
(B) in the livers of 10-week old pullets after treatment for 6h and 12 h, respectively. At the
same sampling time (6h or 12h), different letters in each figure indicate a significant
difference among different 17β-estradiol concentrations (P < 0.05). ApoVLDLⅡ was used
as a positive control in response to the 17β-estradiol. For each treatment, data was
expressed as means ± SD (n=10).
Fig. 5. Effects of the ER antagonists on 17β-estradiol induced expression of cathepsin
E-A-like mRNA in chicken embryo hepatocytes. E2:17β-estradiol (100 nM); ICI: ICI
182,780 (1 μM), TAX: tamoxifen (1 μM), and MPP: (1, 3-bis
(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy) phenol]-1H-pyrazoledihydrochloride)
(1 μM). Different letters indicate significant difference among different treatments (P <0.05).
For each treatment, data was expressed means ± SD (n=6).